Join
Live feed
·
INSIDERFilingvia Quantisnow
Barinthus Biotherapeutics plc logo

Director Dawes Karen A returned 1,700 units of Ordinary Shares to the company, closing all direct ownership in the company (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
BRNS· Barinthus Biotherapeutics plc
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BRNS (Barinthus Biotherapeutics plc) and more on Quantisnow.